Pharmaco-metabolomics

Pharmaco-metabolomics used to determine the metabolic biomarkers that could potentially predict different responses of clinical drugs by identifying differential metabolites at baseline and correlating their variations with the therapeutic outcomes. Presently, Pharmaco-metabolomics remains in its infancy because most pharmaco-metabolomics studies are merely focused on revealing the correlation between baseline metabotypes which are influenced by factors like-gut, ages, drug intake and diets microbiota with drug responses or disease susceptibility to review and decrease the metabolic bases.

 

    Related Conference of Pharmaco-metabolomics

    March 15-16, 2021

    12th Tissue Repair and Regeneration Congress

    Dubai, UAE
    March 28-29, 2021

    11th Glycobiology World Congress

    Vienna, Austria
    April 19-19, 2021

    2nd International Conference on Nucleic Acids

    London, UK
    June 11-12, 2021

    25th Global Congress on Biotechnology

    Berlin, Germany
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland

    Pharmaco-metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in